Clinical Trial Update: Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea

View source ↗

Summary

A completed South Korea clinical trial studied practice patterns and patient compliance with proton pump inhibitor therapy for gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Gastroesophageal Reflux | Status: COMPLETED